Invention Grant
- Patent Title: C,O-spiro aryl glycoside compounds, preparation therefor and use thereof
-
Application No.: US15738675Application Date: 2016-06-23
-
Publication No.: US10550143B2Publication Date: 2020-02-04
- Inventor: Hong Liu , Jia Li , Jiang Wang , Jingya Li , Hui Chen , Dan Li , Jian Li , Yibing Wang , Hualiang Jiang , Kaixian Chen
- Applicant: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
- Applicant Address: CN Shanghai
- Assignee: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Current Assignee: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Current Assignee Address: CN Shanghai
- Agency: Panitch Schwarze Belisario & Nadel LLP
- Priority: CN201510353843 20150623
- International Application: PCT/CN2016/086892 WO 20160623
- International Announcement: WO2016/206604 WO 20161229
- Main IPC: C07H19/01
- IPC: C07H19/01 ; A61P3/08
Abstract:
C, O-spiro aryl glycoside compounds are provided. Specifically provided are C, O-spiro aryl glycoside compounds represented by the formula (I), wherein the definitions of each variable group are described in the specification. Also provided are methods of preparing and using the C, O-spiro aryl glycoside compounds. The C, O-spiro aryl glycoside compounds can be used as SGLT2 inhibitors and for treating diseases, such as diabetes, atherosclerosis, and adiposity.
Public/Granted literature
- US20180305390A1 C,O-SPIRO ARYL GLYCOSIDE COMPOUNDS, PREPARATION THEREFOR AND USE THEREOF Public/Granted day:2018-10-25
Information query
